ERBB2 and neoplasm: At 1 h post-injection, both SPNs and STPNs exhibited FL accumulation at the tumor site compared to free Pu18, but the FL intensity in STPNs was significantly greater than that of SPNs, indicating the robust tumor-targeting and retention capabilities of STPNs via HER2-mediated endocytosis (Fig. 6a).